Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2025-05-29 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
关于注销部分募集资金专项账户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the cancellation of a specific fundraising special account after the funds have been fully used. It details the fundraising amount, the management of the funds, and the closure of a particular account. There are no financial statements or detailed financial performance data presented. The document is relatively short (1421 characters) and serves as a formal notification about the status of fundraising accounts. This fits the category of Capital/Financing Update (CAP), as it relates to the management and status of capital raised by the company.
2025-05-29 Chinese
2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2024 annual equity distribution (dividend) plan by Ningbo New Zhi Biotechnology Co., Ltd. It details the dividend amount, the basis for distribution, tax withholding policies, ex-dividend and record dates, and payment methods. It references the shareholders' meeting resolution approving the plan but does not contain financial statements or detailed financial performance data. The document is relatively short (1817 characters) and focuses solely on dividend distribution details. Therefore, it fits the category of a Notice of Dividend Amount (DIV) rather than an Annual Report or Earnings Release.
2025-05-20 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Ningbo Xinzhi Biotechnology Co., Ltd. regarding the progress of using part of idle raised funds for cash management. It includes specifics about authorized cash management, types of financial products invested in, amounts, expected yields, investment terms, risk control measures, and detailed tables of ongoing and matured cash management products. The document is a regulatory disclosure about the company's use of idle raised funds for cash management purposes, which is a typical capital/financing update. It is not a full financial report, audit report, or earnings release, nor is it a voting result or management change announcement. The document is lengthy (15,000 characters) and contains substantive financial data related to capital management activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-05-19 Chinese
2024年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2024 Annual General Meeting Resolution Announcement" from Ningbo Xinzhi Biotechnology Co., Ltd. It details the convening and attendance of the 2025 AGM, including voting results on various proposals such as the 2024 annual report, board work report, supervisory board report, financial statements, dividend distribution plan, and other related matters. The document includes voting percentages and confirms the legality and validity of the meeting and resolutions. It does not contain the full annual report or financial statements themselves but rather the official announcement of the shareholder meeting resolutions and voting outcomes. The document length is under 5,000 characters and is clearly an announcement of AGM resolutions rather than the report or presentation materials themselves. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-14 Chinese
北京炜衡（宁波）律师事务所关于宁波新芝生物科技股份有限公司 2024 年年度股东会之法律意见书
AGM Information Classification · 88% confidence The document is a legal opinion letter (“法律意见书”) issued by the company’s law firm concerning the convening, attendance, voting procedures, and results of the 2024 annual general meeting (AGM). It is intended to be published as part of the AGM materials (“随其他资料一起向社会公众披露”). This clearly makes it a material shared for the AGM itself rather than an announcement of a report, an earnings release, or any other financial filing. Therefore, it falls under the “AGM Information” category (AGM-R).
2025-05-14 Chinese
投资者关系活动记录表
Call Transcript Classification · 95% confidence The document is an investor relations activity record specifically for a performance briefing (业绩说明会) held on May 9, 2025, discussing the company's 2024 annual results and answering investor questions. It includes detailed Q&A about business performance, market outlook, financial health, dividend policy, share repurchases, and growth strategies. The document is relatively short (3150 characters) and focuses on the content of the earnings explanation meeting rather than presenting full financial statements or comprehensive financial data. This matches the characteristics of a Call Transcript (CT) or earnings conference call transcript rather than a formal Earnings Release (ER) or Interim/Annual Report. Since it is a transcript of a performance briefing with Q&A, the best fit is Call Transcript (CT).
2025-05-12 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.